H.R. 5304
Referred to CommitteePBM Transparency in Prescription Drug Costs Act
Introduced 12/4/2019•116th Congress•House
Latest Action
Referred to the Subcommittee on Health.
12/5/2019 • House
Summary
PBM Transparency in Prescription Drug Costs Act
This bill requires group health plans or the pharmacy benefits manager (PBM) for the plans to periodically report certain prescription drug pricing and utilization data; it also requires PBMs to pass on to health plans all rebates and discounts received from drug manufacturers.
Introduced in House • 12/4/2019
Enter your district to see how this bill affects your community
Topics & Subjects
Policy Area: Health
Business recordsEmployee benefits and pensionsHealth care costs and insuranceHealth information and medical recordsPrescription drugsRight of privacy
Congressional Votes (0)
No recorded votes yet
Roll call votes will appear here as the bill moves through Congress
Related Federal Spending
Sponsor & Cosponsors (2)
Party Breakdown
1
Democrats
1
Republicans
0
Independents
Sponsor
R[
Cosponsors (1)
RL
Bill Journey
Originated in the House
Introduced
December 4, 2019
Referred to the House Committee on Energy and Commerce.
Committee Review
Floor Debate
Passed Chamber
Other Chamber
President
Enacted into Law
Text Versions (1)
Introduced in House12/4/2019